Nagato Kuriyama

A head holder for magnetic resonance imaging that allows the stereotaxic alignment of spontaneously occurring intracranial mouse tumors

M. Israel, M. Wendland, Nathan P Watson, 2002, Journal of Neuroscience Methods.

Dynamic contrast‐enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti‐angiogenic therapy in a xenograft model of glioblastoma multiforme

Robert C Brasch, Timothy P L Roberts, T. Helbich, 2002, Journal of magnetic resonance imaging : JMRI.

Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy.

M. Israel, K. Lamborn, C. Julin, 2000, Human gene therapy.

Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.

M. Israel, K. Lamborn, C. Julin, 2001, Cancer research.

Advances in Brief Protease Pretreatment Increases the Efficacy of Adenovirus-mediated Gene Therapy for the Treatment of an Experimental Glioblastoma Model 1

M. Israel, K. Lamborn, C. Julin, 2001 .

Genetic determinants of malignancy in a mouse model for oligodendroglioma.

William A Weiss, K. Aldape, R. DePinho, 2003, Cancer research.

Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.

B. Scheithauer, J. O'fallon, J. Buckner, 2002, Neuro-oncology.

Prognostic signi cance of an apoptotic index and apoptosis / proliferation ratio for patients with high-grade astrocytomas 1

B. Scheithauer, J. O'fallon, J. Buckner, 2005 .

Molecular genetics of brain tumors.

M. Israel, J. R. Hill, H. Kuriyama, 1999, Archives of neurology.